Bernstein Clinical Research Center

Cincinnati, Ohio 45242

1 studies enrolling now · 30 studies all time

What they study most

Allergic Rhinitis, Allergic Rhinitis Due to Dermatophagoides Farinae, Allergic Rhinitis Due to Dermatophagoides Pteronyssinus, Allergic Rhinitis Due to House Dust Mite, Allergy, Peanut, Angioedema, Asthma, Atopic Dermatitis, Chronic Idiopathic Urticaria, Chronic Inducible Urticaria, Chronic Obstructive Pulmonary Disease, Chronic Spontaneous Urticaria

Studies at this site

• A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines — Recruiting now
• Study of BLU-808 in Chronic Inducible Urticaria (CIndU) and Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• Phase 2b Study of EVO756 in Adults With Moderate to Severe Chronic Spontaneous Urticaria (CSU) — Completed
• Double-blind, Randomized, Placebo-controlled Study Evaluating Efficacy and Safety of IgPro20 in Post-COVID-19 POTS — Stopped early
• Efficacy and Safety of QGE031 (Ligelizumab) in Patients With Peanut Allergy — Stopped early
• House Dust Mite Allergy Trial In Children — Completed
• Expanded Access for the Prevention of Acute Attacks of 1) Hereditary Angioedema (HAE) in Children and 2) Non-histaminergic Angioedema With Normal C1-Inhibitor (C1-INH) in Teenagers and Adults — NO_LONGER_AVAILABLE
• The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment — Completed
• A Study of Lanadelumab to Prevent Hereditary Angioedema (HAE) Attacks in Children — Completed
• Real-World AR101 Market-Supporting Experience Study in Peanut-Allergic Children (RAMSES) — Completed
• AR101 Real-World Open-Label Extension Study — Completed
• Efficacy and Safety of a Retinoid in the Treatment of Severe Chronic Hand Eczema — Completed
• Treatment of Chronic Urticarial Unresponsive to H1-antihistamines With an Anti-IL5Ralpha Monoclonal Antibody — Completed
• An Evaluation Of PF-03715455 In Moderate To Severe Uncontrolled Asthma — Stopped early
• Efficacy and Safety Study of TOLAMBA™ in Ragweed-Allergic Adults — Stopped early
• Safety and Efficacy Trial of Dymista Nasal Spray in Children Ages 4 to 11 With Seasonal Allergic Rhinitis (SAR) — Completed
• A Study to Evaluate the Safety and Tolerability of a Nasal Spray to Treat Perennial Allergic Rhinitis — Completed
• 3 Month Safety Study of Dymista Nasal Spray and Fluticasone Propionate in Children 4-11 Years of Age With Allergic Rhinitis — Completed
• Efficacy Study of Sublingual Immunotherapy to Treat Ragweed Allergies — Completed
• A Phase 2A Study to Evaluate the Safety and Effect on Exercise Challenge Testing of MEDI-528 in Adults With Asthma — Stopped early
• Safety Study of Arformoterol Tartrate Inhalation Solution in Chronic Obstructive Pulmonary Disease (COPD) Subjects — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies — Completed
• A Study to Evaluate the Safety and Efficacy of a Nasal Spray to Treat Children With Perennial Allergic Rhinitis — Completed
• Efficacy and Safety of Omalizumab in Children (6 - < 12 Years) With Moderate-severe, Inadequately Controlled Allergic Asthma — Completed
• A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Perennial Allergies — Completed
• A Study of the Treatment-Sparing Effects of AEROVANT™ AER 001 Inhalation Powder in Asthma Patients, AEROTRIAL — Completed
• A Study to Evaluate the Safety and Efficacy of Two Nasal Sprays to Treat Seasonal Allergies — Completed
• Safety Study of Zileuton Injection in Patients With Asthma — Completed